- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03406390
The Effects of Primary Pterygium on Contrast Sensitivity Preoperatively and Postoperatively
Study Overview
Detailed Description
There would have two groups included in our study, which are primary pterygium group(40 patients) and the normal group (20 volunteers). The inclusion criteria for the primary pterygium group were: 1) more than 18 and less than 60 years old; 2)diagnosed as primary pterygium by the professional doctor; 3)0.0 or better logMAR BCVA; 4) absence of other ocular disorders and no history of eye surgery and other systemic diseases. The inclusion criteria for the normal group were: 1) between 18 and 60 years old; 2) 0.0 or better logMAR BCVA;3) no history of any ocular pathology, and normal physical and mental health.
All the subjects would receive the ophthalmic examination and contrast sensitivity test (quick contrast sensitivity function, quick CSF), in which the pterygium group would achieve the pterygium surgery by the same surgeon (Jin Yuan) and then be performed the contrast sensitivity test on the 1st, 3rd and 6th month postoperatively.
The quick CSF method, implemented in a 10 alternative forced-choice digit identification task, was used to assess the contrast sensitivity function34, 38. Stimuli were displayed on a gamma-corrected 46 inch LCD monitor (Model: NEC LCD P463) with a 1920×1080 pixel resolution, 50 cd/m2 mean luminance and 60 Hz vertical refresh rate. Observers viewed the display monocularly from a distance of 4 m in a dark room. For each trial, they were asked to verbally report the identities of three digits presented on the screen to the experimenter, who used the computer keyboard to enter their responses. The stimuli disappeared after all the responses were entered. Observers were given the option to report ''I don't know'' upon which the response was coded as incorrect. No feedback was provided. All three responses were used to update the posterior distribution of the CSF parameters, which in turn was used to adaptively choose the most informative combination of spatial frequency and contrast for the next trial. A new trial started 500 ms after the responses. There were 30 trials in approximately 5 min. The quick CSF data were scored to generate the cutoff spatial frequency, defined as the spatial frequency corresponding to a perceptual sensitivity of 1, and the area under the log CSF (AULCSF), a summary measure of the window to spatial vision
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Recruiting
- Zhongshan Opthalmic Center
-
Contact:
- Jin Yuan
- Phone Number: 8602087333391
- Email: yuanjincornea@126.com
-
Principal Investigator:
- Jin Yuan, Professor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical diagnosis of the primary pterygium;
- More than 18 and less than 60 years old;
- 0.0 or better logMAR BCVA;
- The absence of other ocular disorders and no history of eye surgery and other systemic diseases.
Exclusion Criteria:
- Clinical diagnosis of recurrent pterygium or accompanied with other ocular diseases;
- less than 18 or more than 60 years old;
- The logMAR BCVA is less than 0.0;
- With the history of eye surgery and other systemic diseases.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
primary pterygium
Observe the contrast sensitivity of primary pterygium patients and healthy control by quick CSF methods, and the pterygium group would achieve the pterygium surgery by the same surgeon (Jin Yuan) and then be performed the contrast sensitivity test on the 1st, 3rd and 6th month postoperatively.
|
The patients were anesthetized with subconjunctival injection.Symblepharon was released and fibrotic tissue was extensively dissected to expose the sclera and corneal stroma.
The subconjunctival fibrovascular tissue, including Tenon's capsule, were thoroughly removed using scissors from the sclera and medial rectus muscle at the area of the superior and inferior fornices and the nasal caruncle.
A cryopreserved human amniotic membrane (Zhongshan Ophthalmic Center, China) was then placed on the entire exposed bare sclera with the epithelial side facing upward, and secured with 10-0 nylon sutures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The contrast sensitivity function tested by quick CSF of the Primary Pterygium patients preoperatively
Time Frame: Preoperatively
|
The contrast sensitivity function of the Primary Pterygium patients is lower than the normal people by qucik CSF method
|
Preoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The contrast sensitivity function tested by quick CSF of the Primary Pterygium patients postoperatively
Time Frame: 1st, 3rd and 6th month postoperatively
|
The contrast sensitivity function of the Primary Pterygium patients is improved compared with the normal people by quick CSF method
|
1st, 3rd and 6th month postoperatively
|
Collaborators and Investigators
Investigators
- Study Director: Jin Yuan, Professor, Zhongshan Ophthalmic Center, Sun Yat-sen University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017011
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Pterygium
-
Meir Medical CenterUnknownPrimary PterygiumIsrael
-
Tianjin Eye HospitalRecruitingPrimary PterygiumChina
-
Universiti Sains MalaysiaCompleted
-
Minia UniversityCompletedPrimary Pterygium, ASOCT, Conjunctival Autograft SurgeryEgypt
-
Hospital de Olhos Sadalla Amin GhanemCompletedPterygium | PrimaryBrazil
-
Instituto de Oftalmología Fundación Conde de ValencianaRecruitingPterygium | Pterygium of Both Eyes | Pterygium of Right Eye | Pterygium of Left EyeMexico
-
Instituto de Oftalmología Fundación Conde de ValencianaCompletedRecurrent Pterygium | Conjunctival ScarringMexico
-
Assiut UniversityNot yet recruitingPterygium | Pterygium of Conjunctiva and Cornea | Pterygium of Both EyesEgypt
-
Brandon Eye Associates, PACompleted
-
University of Split, School of MedicineUniversity Hospital of SplitRecruitingPterygium of Conjunctiva and CorneaCroatia
Clinical Trials on Pterygium surgery
-
University of Sao PauloCompletedConjunctival Diseases | PterygiumBrazil
-
Zahedan University of Medical SciencesRecruitingPterygium of the Conjunctiva and CorneaIran
-
Hospital Authority, Hong KongCompleted
-
Hospital Authority, Hong KongUnknownEffect of Pterygium Excision on Intraocular Lens Power Calculation for Subsequent Cataract OperationCataract | Astigmatism | PterygiumChina
-
Hospital Authority, Hong KongUnknownCataract | Pterygium | Lenses, IntraocularChina
-
Mughal Eye Trust HospitalEnrolling by invitationCorneal Astigmatism | PterygiumPakistan
-
Anguria, Peter, M.D.CompletedPterygiumSouth Africa
-
Kyungpook National University HospitalCompletedRecurrent PterygiumKorea, Republic of
-
Hospital de Olhos Sadalla Amin GhanemCompletedPterygium | PrimaryBrazil